Real-life prospective study on tocilizumab in severe COVID-19 infection

被引：0
|
作者：
Power, L. [1 ]
Morarasu, B. [1 ]
Sarfaraz, A. [1 ]
Basirat, A. [1 ]
Rahman, H. [1 ]
Donnelly, S. [1 ]
Moloney, E. [1 ]
Kooblall, M. [1 ]
Lane, S. [1 ]
机构：
[1] Tallaght Univ Hosp, Dublin, Ireland
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Covid-19; Treatments; Acute respiratory failure;
D O I：
10.1183/13993003.congress-2022.3708
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3708
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia
    Alex, Ruth
    Gulam, Shabaz Mohiuddin
    Kumar, Kiran
    [J]. ADVANCES IN VIROLOGY, 2022, 2022
  • [2] Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study
    Vivarelli, Emanuele
    Matucci, Andrea
    Lucenteforte, Ersilia
    Bormioli, Susanna
    Virgili, Gianni
    Trotta, Michele
    Spinicci, Michele
    Bartoloni, Alessandro
    Zammarchi, Lorenzo
    Peris, Adriano
    Pieralli, Filippo
    Lavorini, Federico
    Fontanari, Paolo
    Morettini, Alessandro
    Nozzoli, Carlo
    Poggesi, Loredana
    Rossi, Oliviero
    Annunziato, Francesco
    Almerigogna, Fabio
    Vultaggio, Alessandra
    [J]. PANMINERVA MEDICA, 2023, 65 (04) : 473 - 478
  • [3] Real-life experience of tocilizumab use in COVID-19 patients
    Madenidou, Anastasia-Vasiliki
    Bukhari, Marwan
    [J]. RHEUMATOLOGY, 2020, 59 (08) : 2163 - 2166
  • [4] Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study
    Russo, Gianluca
    Solimini, Angelo
    Zuccala, Paola
    Zingaropoli, Maria Antonella
    Carraro, Anna
    Pasculli, Patrizia
    Perri, Valentina
    Marocco, Raffaella
    Kertusha, Blerta
    Del Borgo, Cosmo
    Del Giudice, Emanuela
    Fondaco, Laura
    Tieghi, Tiziana
    D'Agostino, Claudia
    Oliva, Alessandra
    Vullo, Vincenzo
    Ciardi, Maria Rosa
    Mastroianni, Claudio Maria
    Lichtner, Miriam
    [J]. PLOS ONE, 2021, 16 (09):
  • [5] Tocilizumab in hospitalized patients with severe COVID-19: an open label, prospective study
    Karampitsakos, Theodoros
    Malakounidou, Elli
    Papaioannou, Ourania
    Dimakopoulou, Vassilina
    Zarkadi, Eirini
    Katsaras, Matthaios
    Tsiri, Panagiota
    Tsirikos, Georgios
    Oikonomou, Ioanna
    Davoulos, Christos
    Georgiopoulou, Vasiliki
    Sampsonas, Fotios
    Marangos, Markos
    Akinosoglou, Karolina
    Tzouvelekis, Argyris
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [6] Tocilizumab in severe COVID-19
    Liberato, Nicola Lucia
    De Monte, Andrea
    Caravella, Giuseppe
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (06) : 1457 - 1458
  • [7] Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia
    Corcione, Silvia
    De Nicolo, Amedeo
    Montrucchio, Giorgia
    Scabini, Silvia
    Avataneo, Valeria
    Bonetto, Chiara
    Pinna, Simone Mornese
    Cusato, Jessica
    Canta, Francesca
    Urbino, Rosario
    Di Perri, Giovanni
    Brazzi, Luca
    De Rosa, Francesco Giuseppe
    D'Avolio, Antonio
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (12) : 4861 - 4867
  • [8] Clinical course of patients with severe COVID-19 pneumonia treated with remdesivir: A real-life study
    Tejada, Diana
    Juanbeltz, Regina
    Rivero, Maria
    San Miguel, Ramon
    Capdevila, Ferran
    Jose Beloqui, Juan
    Sarobe, Maite
    [J]. PLOS ONE, 2022, 17 (04):
  • [9] Ruxolitinib for tocilizumab-refractory severe COVID-19 infection
    Innes, Andrew J.
    Cook, Lucy B.
    Marks, Sasha
    Bataillard, Edward
    Crossette-Thambiah, Christina
    Sivasubramaniam, Gayathiri
    Apperley, Jane
    Milojkovic, Dragana
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (04) : E198 - E200
  • [10] Effects of COVID-19 Infection and Vaccines on Patients with Epilepsy: Real-Life Experiences
    Ocek, Ozge
    Ortan, Pinar
    [J]. NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2023, 60 (04): : 315 - 315
12345